http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017239033-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c11d10b19952d4afc988be14c8f381f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-966 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0069 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-90 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14 |
| filingDate | 2015-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d20aeab17438e94d6e68183dd59f161 |
| publicationDate | 2017-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2017239033-A1 |
| titleOfInvention | 3d filter for prevention of stroke |
| abstract | The present invention relates to implantable endoluminal prosthesis for preventing stroke. The endoluminal prosthesis ( 1 ) consists of a braided framework ( 20 ) defining a cylindrical lumen ( 21 ) devoid of impermeable membrane. Said braided framework ( 20 ) is self-expandable comprising a plurality of layers ( 22, 23, 24 ) of wires ( 25 ) made of biocompatible material. Each layer forms a mesh. The meshes form a lattice with a plurality of wires ( 2 ) of given layers ( 22, 23, 24 ). The lattice defines polygonal opening units ( 26 ) when observed normal to a wall of the implantable endoluminal prosthesis ( 1 ). The diameter (Ø 25 ) of wire ( 25 ) being at least 30 μm and at most 150 μm, the mean diameter (Ø 27 ) of the inscribed circle ( 27 ) of the polygonal opening units ( 26 ) being at least 75 μm and at most 200 μm in fully expanded state. The braided framework ( 20 ) consists of at least 128 and at most 512 wires ( 25 ). The ratio (T 1 /Ø 25 ) of the thickness (T 1 ) of a wall of said implantable endoluminal prosthesis ( 1 ) to the diameter (Ø 25 ) of wire ( 25 ) is at least 3.0. In a fully expanded state, the surface coverage ratio (SCR) of said braided framework ( 20 ) is more than 50% and less than 90%. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10335259-B2 |
| priorityDate | 2014-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.